Inactivation of anthracyclines by cellular peroxidase

Cancer Research

Volumn 65, Issue 14, 2005, Pages 6346-6353

  Reszka, Krzysztof J ^a,b   Wagner, Brett A ^b   Teesch, Lynn M ^b   Britigan, Bradley E ^a,b   Spitz, Douglas R ^b   Burns, C Patrick ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHOXYPHTHALIC ACID; 3 METHOXYSALICYLIC ACID; 4 AMINOBENZOIC ACID; ANTHRACYCLINE DERIVATIVE; DAUNORUBICIN; DOXORUBICIN; HYDRAZIDE; HYDROGEN PEROXIDE; MYELOPEROXIDASE; NITRITE; PEROXIDASE; PHTHALIC ACID DERIVATIVE; SALICYLIC ACID DERIVATIVE; THIAMAZOLE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CELL SURVIVAL; CHROMATOPHORE; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DEGRADATION; DRUG INACTIVATION; DRUG METABOLISM; DRUG OXIDATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RAT; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOTRANSFORMATION; CELL LINE, TUMOR; DAUNORUBICIN; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; HL-60 CELLS; HUMANS; MALE; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; PEROXIDASE; PHTHALIC ACIDS; PROSTATIC NEOPLASMS; RATS; SALICYLIC ACIDS;

EID: 22244436269     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2312     Document Type: Article

References (44)

1. Brangi M, Litman T, Ciotti M, et al. Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells. Cancer Res 1999;59:5938-46.
2. Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 2003;22:7340-58.
3. Klein I, Sarkadi B, Varadi A. An inventory of the human ABC proteins. Biochim Biophys Acta 1999;1461:237-62.
4. Licata S, Saponiero A, Mordente A, Minotti G. Doxorubicin metabolism and toxicity in human myocardium: role of cytoplasmic deglycosidation and carbonyl reduction. Chem Res Toxicol 2000;13:414-20.
5. Ax W, Soldan M, Koch L, Maser E. Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction. Biochem Pharmacol 2000;59:293-300.
6. Soldan M, Netter KJ, Maser E. Induction of daunorubicin carbonyl reducing enzymes by daunorubicin in sensitive and resistant pancreas carcinoma cells. Biochem Pharmacol 1996;51:117-23.
7. Mordente A, Meucci E, Martorana GE, Giardina B, Minotti G. Human heart cytosolic reductases and anthracycline cardiotoxicity. IUBMB Life 2001;52:83-8.
8. Bachur NR, Gordon SL, Gee MV, Kon H. NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc Natl Acad Sci USA 1979;76:954-7.
9. Davies KJ, Doroshow JH. Redox cycling of anthracyclines by cardiac mitochondria, I. Anthracycline radical formation by NADH dehydrogenase. J Biol Chem 1986;261:3060-7.
10. Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin. Biochem Pharmacol 1999;57:727-41,
11. Keizer HG, Pinedo HM, Schuurhuis GJ, Joenje H. Doxorubicin (Adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Ther 1990;47:219-31.
12. Kolodziejczyk P, Reszka K, Lown JW. Enzymatic oxidative activation of 5-iminodaunorubicin. Spectro-photometric and electron paramagnetic resonance studies. Biochem Pharmacol 1989;38:803-9.
13. Reszka KJ, McCormick ML, Britigan BE. Peroxidase- and nitrite-dependent metabolism of the anthracycline anticancer agents daunorubicin and doxorubicin. Biochemistry 2001;40:15349-61.
14. Reszka KJ, McCormick ML, Britigan BE. Oxidation of anthracycline anticancer agents by the peroxidase mimic microperoxidase 11 and hydrogen peroxide. Free Radic Biol Med 2003;35:78-93.
15. Menna P, Salvatorelli E, Giampietro R, et al. Doxorubicin-dependent reduction of ferrylmyoglobin and inhibition of lipid peroxidation: implications for cardiotoxicity of anticancer anthracyclines. Chem Res Toxicol 2002;15:1179-89.
16. Cartoni A, Menna P, Salvatorelli E, et al. Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin. J Biol Chem 2004;279:5088-99.
17. Reszka KJ, Britigan LH, Rasmussen GT, Wagner BA, Burns CP, Britigan BE. Acetaminophen stimulates the peroxidative metabolism of anthracyclines. Arch Biochem Biophys 2004;427:16-29.
18. -): an EPR and spin trapping study. Free Radic Biol Med 1999;26:669-78.
19. Muraoka S, Miura T. Inactivation of mitochondrial succinate dehydrogenase by Adriamycin activated by horseradish peroxidase and hydrogen peroxide. Chem Biol Interact 2003;145:67-75.
20. Miura T, Muraoka S, Fujimoto Y. Inactivation of creatine kinase by Adriamycin during interaction with horseradish peroxidase. Biochem Pharmacol 2000;60:95-9.
21. Bomgaars L, Gunawardena S, Kelley SE, Ramu A. The inactivation of doxorubicin by long ultraviolet light. Cancer Chemother Pharmacol 1997;40:506-12.
22. Reszka KJ, Britigan LH, McCormick ML, Britigan BE, Spitz DR. Do pain killers counteract the anticancer action of anthracyclines? In: 2nd International Conference on Prostate Cancer Research; 2002; Iowa City, IA; 2002.
23. Ramu A, Mehta MM, Liu J, Turyan I, Aleksic A. The riboflavin-mediated photooxidation of doxorubicin. Cancer Chemother Pharmacol 2000;46:449-58.
24. 2-induced apoptosis of HL-60 human leukemia cells. J Biol Chem 2000;275:22461-9.
25. Wagner BA, Britigan BE, Reszka KJ, McCormick ML, Burns CP. Hydrogen peroxide-induced apoptosis of HL-60 human leukemia cells is mediated by the oxidants hypochlorous acid and chloramines. Arch Biochem Biophys 2002;401:223-34.
26. 2-resistant cell lines. Do aldehydic by-products of lipid peroxidation contribute to oxidative stress? Biochem J 1990;267:453-9.
27. Chaires JB, Dattagupta N, Crothers DM. Self-association of daunomycin. Biochemistry 1982;21:3927-32.
28. Wentzel BB, Donners MPJ, Alsters PL, Feiters MC, Nolte RJM. N-hydroxyphthalimide/cobalt(II) catalyzed low temperture benzylic oxidation using molecular oxygen. Tetrahedron 2000;56:7797-803.
29. Gaston B, Reilly J, Drazen JM, et al. Endogenous nitrogen oxides and bronchodilator 5-nitrosothiols in human airways. Proc Natl Acad Sci U S A 1993;90:10957-61.
30. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126:131-8.
31. Nauseef WM. Myeloperoxidase biosynthesis by a human promyelocytic leukemia ceil line: insight into myeloperoxidase deficiency. Blood 1986;67:865-72.
32. Klebanoff SJ, Myeloperoxidase: Occurrence and biological function, In: Everse J, Everse KE, Grisham MB, editors. Peroxidases in chemistry and biology. Boca Raton: CRC Press; 1991. p. 1-35.
33. Kettle AJ, Gedye CA, Winterbourn CC. Mechanism of inactivation of myeioperoxidase by 4-aminobenzoic acid hydrazide. Biochem J 1997;321:503-8.
34. Wagner BA, Reszka KJ, McCormick ML, Britigan BE, Evig CB, Burns CP. Role of thiocyanate, bromide and hypobromous acid in hydrogen peroxide-induced apoptosis. Free Radic Res 2004;38:167-75.
35. DeAtley SM, Aksenov MY, Aksenova MV, Jordan B, Carney JM, Butterfield DA. Adriamycin-induced changes of creatine kinase activity in vivo and in cardiomyocyte culture. Toxicology 1999;134:51-62.
36. DeAtley SM, Aksenov MY, Aksenova MV, et al. Antioxidants protect against reactive oxygen species associated with Adriamycin-treated cardiomyocytes. Cancer Lett 1999;136:41-6.
37. Konorev EA, Kennedy MC, Kalyanaraman B. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates. Arch Biochem Biophys 1999;368:421-8.
38. Bloom J, Lehman P, Israel M, Rosario O, Korfmacher WA. Mass spectral characterization of three anthracycline antibiotics: a comparison of thermospray mass spectrometry to particle beam mass spectrometry. J Anal Toxicol 1992;16:223-7.
39. Lachatre F, Marquet P, Ragot S, Gaulier JM, Cardot P, Dupuy JL. Simultaneous determination of four anthracyclines and three metabolites in human serum by liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl 2000;738:281-91.
40. Bruck TB, Fielding RJ, Symons MC, Harvey PJ. Mechanism of nitrite-stimulated catalysis by lactoperoxidase. Eur J Biochem 2001;268:3214-22.
41. Burner U, Furtmuller PG, Kettle AJ, Koppenol WH, Obinger C. Mechanism of reaction of myeloperoxidase with nitrite. J Biol Chem 2000;275:20597-601.
42. Aldieri E, Bergandi L, Riganti C, Costamagna C, Bosia A, Ghigo D. Doxorubicin induces an increase of nitric oxide synthesis in rat cardiac cells that is inhibited by iron supplementation. Toxicol Appl Pharmacol 2002;185:85-90.
43. Lind DS, Kontaridis MI, Edwards PD, Josephs MD, Moldawer LL, Copeland EM III. Nitric oxide contributes to Adriamycin's antitumor effect. J Surg Res 1997;69:283-7.
44. Reszka KJ, McCormick ML, Britigan BE, Tyrosine and ABTS enhance and ascorbate and cysteine inhibit the peroxidative metabolism of anthracyclines. Free Rad Biol Med 2001;31:5140.